News from johnson & johnson A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

19:10 ET Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization...

Feb 26, 2021, 17:43 ET Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological...

Feb 19, 2021, 07:30 ET Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE: JNJ) (the Company) announced that Janssen-Cilag International N.V. has submitted for Emergency Use Listing (EUL) to the...

Feb 04, 2021, 17:35 ET Johnson & Johnson Announces Submission of Application to the U.S. FDA for Emergency Use Authorization of its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that Janssen Biotech, Inc., has submitted an application to the U.S. Food and Drug...

Jan 29, 2021, 08:00 ET Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial

Johnson & Johnson (NYSE: JNJ) (the Company) today announced topline efficacy and safety data from the Phase 3 ENSEMBLE clinical trial, demonstrating...

Jan 26, 2021, 06:42 ET Johnson & Johnson Reports 2020 Fourth-Quarter And Full Year Results

Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2020. "Our notable full year performance reflects the...

Jan 04, 2021, 08:30 ET Johnson & Johnson Announces Quarterly Dividend for First Quarter 2021

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the first quarter of 2021 of $1.01 per...

Dec 03, 2020, 16:05 ET Johnson & Johnson Names Dr. Nadja West, retired United States Army lieutenant general and former United States Army Surgeon General to its Board of Directors

Johnson & Johnson (NYSE: JNJ) announced today that Dr. Nadja West, retired United States Army lieutenant general and former United States Army...

Dec 03, 2020, 06:30 ET Johnson & Johnson Announces Fireside Chat Webcast on Janssen's Eye Disease Portfolio

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced a new pre-recorded fireside chat webcast focused on the company's eye...

Dec 01, 2020, 08:00 ET New Survey Finds Critical Need for Education on Cataracts and Modern Treatment Options

Today, Johnson & Johnson Vision* announced findings from a new survey** that assessed awareness of cataracts among adults around the world. Cataracts ...

Nov 17, 2020, 08:00 ET Johnson & Johnson to Address Racial and Social Injustice Through Platform that Aims to Eliminate Health Inequities for People of Color

Johnson & Johnson (NYSE: JNJ) announced today $100 million in commitments and collaborations over the next five years to invest in and promote health ...

Nov 14, 2020, 09:34 ET Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase of COVID-19 Vaccine Candidate Research and Development

Johnson & Johnson (NYSE: JNJ) (the Company) announced the expansion to the partnership between its Janssen Pharmaceutical Companies (Janssen) and the ...

Nov 06, 2020, 08:30 ET Johnson & Johnson to Host Virtual Medical Devices Update

Johnson & Johnson (NYSE: JNJ) will hold a virtual Medical Devices Update for the investment community on Thursday, November 19, 2020, in which...

Oct 22, 2020, 14:16 ET Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2020

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2020 of $1.01 per...

Oct 13, 2020, 06:39 ET Johnson & Johnson Reports 2020 Third-Quarter Results

Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2020. "Our third-quarter results reflect solid performance and positive...

Oct 10, 2020, 10:09 ET A Johnson & Johnson anuncia a aprovação pela Comissão Europeia do contrato para fornecer 200 milhões de doses da candidata à vacina da Janssen para a COVID-19

A Johnson & Johnson (NYSE: JNJ) (a Empresa) anunciou hoje que a Comissão Europeia (CE), em nome dos Estados-membros da União Europeia (UE), aprovou...

Oct 09, 2020, 07:14 ET Johnson & Johnson anuncia aprobación por parte de la Comisión Europea del acuerdo para proveer 200 millones de dosis de la candidata para vacuna contra la COVID-19 de Janssen

Johnson & Johnson (NYSE: JNJ) (la compañía) anunció hoy que la Comisión Europea (CE), actuando en nombre de los estados miembros de la Unión Europea...

Oct 08, 2020, 07:50 ET Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the European Commission (EC), acting on behalf of the European Union (EU) Member States,...

Oct 01, 2020, 08:40 ET Johnson & Johnson Completes Acquisition of Momenta Pharmaceuticals, Inc.

Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc. ("Momenta"), a company...

Sep 24, 2020, 14:17 ET A Johnson & Johnson inicia a Fase 3 do principal estudo clínico global da candidata à vacina contra a COVID-19 da Janssen

Johnson & Johnson (NYSE: JNJ) (a empresa) anunciou hoje o lançamento da Fase 3 do seu estudo clínico em grande escala, fundamental e multinacional (o ...

Sep 24, 2020, 14:11 ET Johnson & Johnson inicia el ensayo clínico de fase 3 de la candidata a la vacuna contra la COVID-19 de Janssen a nivel global

Johnson & Johnson (NYSE: JNJ) (la Empresa) anunció hoy el lanzamiento de su ensayo de fase 3 (ENSEMBLE) pivotal, a gran escala y para múltiples...

Sep 23, 2020, 06:45 ET Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate

Johnson & Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its...

Sep 14, 2020, 08:58 ET Call for Award Applicants: Johnson & Johnson Seeks Female Researchers Working in Science, Technology, Engineering, Math, Manufacturing and Design

Johnson & Johnson today announced that it is accepting applications for its 2021 Women in STEM2D (WiSTEM2D) Scholars Award, aimed at supporting...

Aug 20, 2020, 09:21 ET Johnson & Johnson Celebrates Role of Scientists In Society with 2020 Dr. Paul Janssen Award for Biomedical Research, Part of the Champions of Science® Initiative

Johnson & Johnson (NYSE: JNJ) today announced Lewis Cantley, Ph.D., of Weill Cornell Medicine and NewYork-Presbyterian as the winner of the 2020 Dr....

Aug 19, 2020, 06:30 ET Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases

Johnson & Johnson (NYSE:JNJ) today announced it has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. (Momenta), a company ...